Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer

J. J. Yeh, N. Y. Hsu, W. H. Hsu, C. H. Tsai, C. C. Lin, J. A. Liang

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The aim of this study was to investigate the expression of P-glycoprotein (Pgp), multidrug resistance-related protein-1 (MRP1), and lung resistance-related protein (LRP) in response to chemotherapy in untreated small cell lung cancer (SCLC). Immunohistochemical analyses were performed on multiple nonconsecutive sections of biopsy specimens to detect Pgp, MRP1, and LRP expression in 40 patients with SCLC before chemotherapeutic induction. Response to chemotherapy was evaluated by clinical and radiological methods. The patients were divided into a good response group (n = 20) and a poor response group (n = 20). No significant differences in prognostic factors (Karnofsky performance status, tumor size, or tumor stage) were found between the two groups of patients. The difference in positive Pgp and MRP1 expressions between the good and poor response groups was significant. However, the difference in LRP expression was not significant. We conclude that chemotherapy response of patients with SCLC was related to either Pgp or MRP1 but not LPR expression.

Original languageEnglish
Pages (from-to)177-183
Number of pages7
JournalLung
Volume183
Issue number3
DOIs
Publication statusPublished - Jun 2005
Externally publishedYes

Fingerprint

Small Cell Lung Carcinoma
P-Glycoprotein
Drug Therapy
Karnofsky Performance Status
major vault protein
Neoplasms
Biopsy

Keywords

  • Chemotherapy response
  • Lung resistance-related protein
  • Multidrug resistance-related protein-1
  • P-glycoprotein
  • Small cell lung cancer

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology

Cite this

Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer. / Yeh, J. J.; Hsu, N. Y.; Hsu, W. H.; Tsai, C. H.; Lin, C. C.; Liang, J. A.

In: Lung, Vol. 183, No. 3, 06.2005, p. 177-183.

Research output: Contribution to journalArticle

Yeh, J. J. ; Hsu, N. Y. ; Hsu, W. H. ; Tsai, C. H. ; Lin, C. C. ; Liang, J. A. / Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer. In: Lung. 2005 ; Vol. 183, No. 3. pp. 177-183.
@article{ff32885e7e9b4bbb8a67d8275df0065a,
title = "Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer",
abstract = "The aim of this study was to investigate the expression of P-glycoprotein (Pgp), multidrug resistance-related protein-1 (MRP1), and lung resistance-related protein (LRP) in response to chemotherapy in untreated small cell lung cancer (SCLC). Immunohistochemical analyses were performed on multiple nonconsecutive sections of biopsy specimens to detect Pgp, MRP1, and LRP expression in 40 patients with SCLC before chemotherapeutic induction. Response to chemotherapy was evaluated by clinical and radiological methods. The patients were divided into a good response group (n = 20) and a poor response group (n = 20). No significant differences in prognostic factors (Karnofsky performance status, tumor size, or tumor stage) were found between the two groups of patients. The difference in positive Pgp and MRP1 expressions between the good and poor response groups was significant. However, the difference in LRP expression was not significant. We conclude that chemotherapy response of patients with SCLC was related to either Pgp or MRP1 but not LPR expression.",
keywords = "Chemotherapy response, Lung resistance-related protein, Multidrug resistance-related protein-1, P-glycoprotein, Small cell lung cancer",
author = "Yeh, {J. J.} and Hsu, {N. Y.} and Hsu, {W. H.} and Tsai, {C. H.} and Lin, {C. C.} and Liang, {J. A.}",
year = "2005",
month = "6",
doi = "10.1007/s00408-004-2532-1",
language = "English",
volume = "183",
pages = "177--183",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer

AU - Yeh, J. J.

AU - Hsu, N. Y.

AU - Hsu, W. H.

AU - Tsai, C. H.

AU - Lin, C. C.

AU - Liang, J. A.

PY - 2005/6

Y1 - 2005/6

N2 - The aim of this study was to investigate the expression of P-glycoprotein (Pgp), multidrug resistance-related protein-1 (MRP1), and lung resistance-related protein (LRP) in response to chemotherapy in untreated small cell lung cancer (SCLC). Immunohistochemical analyses were performed on multiple nonconsecutive sections of biopsy specimens to detect Pgp, MRP1, and LRP expression in 40 patients with SCLC before chemotherapeutic induction. Response to chemotherapy was evaluated by clinical and radiological methods. The patients were divided into a good response group (n = 20) and a poor response group (n = 20). No significant differences in prognostic factors (Karnofsky performance status, tumor size, or tumor stage) were found between the two groups of patients. The difference in positive Pgp and MRP1 expressions between the good and poor response groups was significant. However, the difference in LRP expression was not significant. We conclude that chemotherapy response of patients with SCLC was related to either Pgp or MRP1 but not LPR expression.

AB - The aim of this study was to investigate the expression of P-glycoprotein (Pgp), multidrug resistance-related protein-1 (MRP1), and lung resistance-related protein (LRP) in response to chemotherapy in untreated small cell lung cancer (SCLC). Immunohistochemical analyses were performed on multiple nonconsecutive sections of biopsy specimens to detect Pgp, MRP1, and LRP expression in 40 patients with SCLC before chemotherapeutic induction. Response to chemotherapy was evaluated by clinical and radiological methods. The patients were divided into a good response group (n = 20) and a poor response group (n = 20). No significant differences in prognostic factors (Karnofsky performance status, tumor size, or tumor stage) were found between the two groups of patients. The difference in positive Pgp and MRP1 expressions between the good and poor response groups was significant. However, the difference in LRP expression was not significant. We conclude that chemotherapy response of patients with SCLC was related to either Pgp or MRP1 but not LPR expression.

KW - Chemotherapy response

KW - Lung resistance-related protein

KW - Multidrug resistance-related protein-1

KW - P-glycoprotein

KW - Small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=23944473868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944473868&partnerID=8YFLogxK

U2 - 10.1007/s00408-004-2532-1

DO - 10.1007/s00408-004-2532-1

M3 - Article

C2 - 16078039

AN - SCOPUS:23944473868

VL - 183

SP - 177

EP - 183

JO - Lung

JF - Lung

SN - 0341-2040

IS - 3

ER -